4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Structure of the lipoprotein lipase–GPIHBP1 complex that mediates plasma triglyceride hydrolysis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          The intravascular processing of triglyceride-rich lipoproteins by the lipoprotein lipase (LPL)–GPIHBP1 complex is crucial for clearing triglycerides from the bloodstream and for the delivery of lipid nutrients to vital tissues. A deficiency of either LPL or GPIHBP1 impairs triglyceride processing, resulting in severe hypertriglyceridemia (chylomicronemia). Despite intensive investigation by biochemists worldwide, the structures for LPL and GPIHBP1 have remained elusive. Inspired by the recent discovery that GPIHBP1 stabilizes LPL structure and activity, we crystallized the LPL–GPIHBP1 complex and solved its structure. The structure provides insights into the ability of GPIHBP1 to preserve LPL structure and activity and also reveals how inherited defects in these proteins impair triglyceride hydrolysis and cause chylomicronemia.

          Abstract

          Lipoprotein lipase (LPL) is responsible for the intravascular processing of triglyceride-rich lipoproteins. The LPL within capillaries is bound to GPIHBP1, an endothelial cell protein with a three-fingered LU domain and an N-terminal intrinsically disordered acidic domain. Loss-of-function mutations in LPL or GPIHBP1 cause severe hypertriglyceridemia (chylomicronemia), but structures for LPL and GPIHBP1 have remained elusive. Inspired by our recent discovery that GPIHBP1’s acidic domain preserves LPL structure and activity, we crystallized an LPL–GPIHBP1 complex and solved its structure. GPIHBP1’s LU domain binds to LPL’s C-terminal domain, largely by hydrophobic interactions. Analysis of electrostatic surfaces revealed that LPL contains a large basic patch spanning its N- and C-terminal domains. GPIHBP1’s acidic domain was not defined in the electron density map but was positioned to interact with LPL’s large basic patch, providing a likely explanation for how GPIHBP1 stabilizes LPL. The LPL–GPIHBP1 structure provides insights into mutations causing chylomicronemia.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          Structure of human pancreatic lipase.

          Pancreatic lipase (triacylglycerol acyl hydrolase) fulfills a key function in dietary fat absorption by hydrolysing triglycerides into diglycerides and subsequently into monoglycerides and free fatty acids. We have determined the three-dimensional structure of the human enzyme, a single-chain glycoprotein of 449 amino acids, by X-ray crystallography and established its primary structure by sequencing complementary DNA clones. Enzymatic activity is lost after chemical modification of Ser 152 in the porcine enzyme, indicating that this residue is essential in catalysis, but other data are more consistent with a function in interfacial recognition. Our structural results are evidence that Ser 152 is the nucleophilic residue essential for catalysis. It is located in the larger N-terminal domain at the C-terminal edge of a doubly wound parallel beta-sheet and is part of an Asp-His-Ser triad, which is chemically analogous to, but structurally different from, that in the serine proteases. This putative hydrolytic site is covered by a surface loop and is therefore inaccessible to solvent. Interfacial activation, a characteristic property of lipolytic enzymes acting on water-insoluble substrates at water-lipid interfaces, probably involves a reorientation of this flap, not only in pancreatic lipases but also in the homologous hepatic and lipoprotein lipases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

            All organisms use fatty acids (FAs) for energy substrates and as precursors for membrane and signaling lipids. The most efficient way to transport and store FAs is in the form of triglycerides (TGs); however, TGs are not capable of traversing biological membranes and therefore need to be cleaved by TG hydrolases ("lipases") before moving in or out of cells. This biochemical process is generally called "lipolysis." Intravascular lipolysis degrades lipoprotein-associated TGs to FAs for their subsequent uptake by parenchymal cells, whereas intracellular lipolysis generates FAs and glycerol for their release (in the case of white adipose tissue) or use by cells (in the case of other tissues). Although the importance of lipolysis has been recognized for decades, many of the key proteins involved in lipolysis have been uncovered only recently. Important new developments include the discovery of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1), the molecule that moves lipoprotein lipase from the interstitial spaces to the capillary lumen, and the discovery of adipose triglyceride lipase (ATGL) and comparative gene identification-58 (CGI-58) as crucial molecules in the hydrolysis of TGs within cells. This review summarizes current views of lipolysis and highlights the relevance of this process to human disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The Lid Domain in Lipases: Structural and Functional Determinant of Enzymatic Properties

              Lipases are important industrial enzymes. Most of the lipases operate at lipid–water interfaces enabled by a mobile lid domain located over the active site. Lid protects the active site and hence responsible for catalytic activity. In pure aqueous media, the lid is predominantly closed, whereas in the presence of a hydrophobic layer, it is partially opened. Hence, the lid controls the enzyme activity. In the present review, we have classified lipases into different groups based on the structure of lid domains. It has been observed that thermostable lipases contain larger lid domains with two or more helices, whereas mesophilic lipases tend to have smaller lids in the form of a loop or a helix. Recent developments in lipase engineering addressing the lid regions are critically reviewed here. After on, the dramatic changes in substrate selectivity, activity, and thermostability have been reported. Furthermore, improved computational models can now rationalize these observations by relating it to the mobility of the lid domain. In this contribution, we summarized and critically evaluated the most recent developments in experimental and computational research on lipase lids.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                29 January 2019
                17 December 2018
                17 December 2018
                : 116
                : 5
                : 1723-1732
                Affiliations
                [1] aDivision of Experimental Medicine, Beth Israel Deaconess Medical Center , Boston, MA 02215;
                [2] bDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles , CA 90095;
                [3] cDiscovery Therapeutics, US Drug Discovery, Shire Pharmaceuticals , Cambridge, MA 02142;
                [4] dFinsen Laboratory, Rigshospitalet , DK-2200 Copenhagen, Denmark;
                [5] eBiotech Research and Innovation Centre, University of Copenhagen , DK-2200 Copenhagen, Denmark;
                [6] fBIOSAXS Group, European Molecular Biology Laboratory Hamburg , D-22607 Hamburg, Germany
                Author notes
                3To whom correspondence may be addressed. Email: sgyoung@ 123456mednet.ucla.edu or mmeiyappan@ 123456shire.com .

                Contributed by Stephen G. Young, November 16, 2018 (sent for review October 29, 2018; reviewed by Fredric B. Kraemer and Rudolf Zechner)

                Author contributions: G.B., K.K.K., O.L.F., L.G.F., M.P., S.G.Y., and M.M. designed research; G.B., A.P.B., B.D., B.S.-L., K.K.K., L.G.F., H.D.T.M., M.P., and M.M. performed research; G.B., A.P.B., B.D., B.S.-L., K.K.K., L.G.F., H.D.T.M., M.P., S.G.Y., and M.M. contributed new reagents/analytic tools; G.B., A.P.B., K.K.K., L.G.F., H.D.T.M., C.Q.P., M.P., S.G.Y., and M.M. analyzed data; and G.B., L.G.F., M.P., S.G.Y., and M.M. wrote the paper.

                Reviewers: F.B.K., Veterans Affairs Palo Alto Health Care System and Stanford University; and R.Z., University of Graz.

                1Present address: Discovery Research, Homology Medicine, Bedford, MA 01730.

                2S.G.Y. and M.M. contributed equally to this work.

                Author information
                http://orcid.org/0000-0002-1759-5499
                http://orcid.org/0000-0002-5664-744X
                http://orcid.org/0000-0003-2215-4265
                http://orcid.org/0000-0002-0466-0458
                Article
                201817984
                10.1073/pnas.1817984116
                6358717
                30559189
                0eb15086-5019-4ea6-8d2a-d0461f03a85a
                Copyright © 2019 the Author(s). Published by PNAS.

                This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).

                History
                Page count
                Pages: 10
                Funding
                Funded by: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 100000050
                Award ID: HL090553
                Award ID: HL087228
                Award ID: HL125335
                Award ID: HL139725
                Award Recipient : Stephen G. Young
                Funded by: Fondation Leducq 501100001674
                Award ID: 12CVD04
                Award Recipient : Stephen G. Young
                Funded by: Lundbeck Foundation Grant
                Award ID: R230-2016-2930
                Award Recipient : Kristian K. Kristensen Award Recipient : Michael Ploug Award Recipient : Muthuraman Meiyappan
                Funded by: NOVO Nordisk Foundation Grant
                Award ID: NNF17OC0026868
                Award ID: NNF18OC0033864
                Award Recipient : Kristian K. Kristensen Award Recipient : Michael Ploug Award Recipient : Muthuraman Meiyappan
                Funded by: Shire US Drug Discovery
                Award ID: !AShire
                Award Recipient : Kristian K. Kristensen Award Recipient : Michael Ploug Award Recipient : Muthuraman Meiyappan
                Categories
                PNAS Plus
                Biological Sciences
                Medical Sciences
                From the Cover
                PNAS Plus

                triglycerides,lipase,lipoproteins,x-ray crystallography,gpihbp1

                Comments

                Comment on this article